Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
40.75 USD | -0.90% |
|
+1.72% | -20.58% |
Jul. 11 | Redburn Atlantic Adjusts Price Target on Bristol-Myers Squibb to $50 From $54, Maintains Neutral Rating | MT |
Jul. 10 | Barclays Adjusts Price Target on Bristol-Myers Squibb to $41 From $43 | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-20.58% | 83.35B | |
+60.25% | 846B | |
+38.56% | 628B | |
-4.49% | 360B | |
+18.30% | 322B | |
+9.64% | 297B | |
+14.15% | 240B | |
+3.11% | 224B | |
+16.98% | 223B | |
+12.87% | 173B |
- Stock Market
- Equities
- BMY Stock
- News Bristol-Myers Squibb Company
- Biden Administration to Lower Costs for 64 Prescription Drugs for Medicare Enrollees